Correlation between progression-free and overall survival in a meta-analysis of aggregated survival data from patients with non-small cell lung cancer

被引：0
|
作者：
Aksenov, Sergey [1 ]
Lee, Daniel [2 ]
Edlund, Helena [1 ]
Minchella, Kaitlyn [1 ]
Xu, Hongmei [1 ]
Dunyak, James [1 ]
Al-Huniti, Nidal [1 ]
机构：
[1] AstraZeneca, Quantitat Clin Pharmacol, Waltham, MA USA
[2] Stan Grp, New York, NY USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-019
引用
收藏
页码：S63 / S64
页数：2
相关论文
共 50 条
  • [1] Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
    Lee, Chee Khoon
    Brown, Chris
    Gralla, Richard J.
    Hirsh, Vera
    Thongprasert, Sumitra
    Tsai, Chun-Ming
    Tan, Eng Huat
    Ho, James Chung-Man
    Chu, Da Tong
    Zaatar, Adel
    Osorio Sanchez, Jemela Anne
    Vu Van Vu
    Au, Joseph Siu Kie
    Inoue, Akira
    Lee, Siow Ming
    Gebski, Val
    Yang, James Chih-Hsin
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (09): : 595 - 605
  • [2] Impact of Advantage in Tumor Response on the Correlation Between Progression-Free Survival and Overall Survival: Meta-Analysis of Clinical Trials in Patients with Advanced Non-Small Cell Lung Cancer
    Yoshida, Yosuke
    Kaneko, Masayuki
    Narukawa, Mamoru
    PHARMACEUTICAL MEDICINE, 2021, 35 (02) : 81 - 92
  • [3] Impact of Advantage in Tumor Response on the Correlation Between Progression-Free Survival and Overall Survival: Meta-Analysis of Clinical Trials in Patients with Advanced Non-Small Cell Lung Cancer
    Yosuke Yoshida
    Masayuki Kaneko
    Mamoru Narukawa
    Pharmaceutical Medicine, 2021, 35 : 81 - 92
  • [4] Meta-analysis of progression-free survival as a predictor of overall survival in locally advanced or metastatic non-small cell lung cancer trials.
    Turner, Evadne Jane
    McCloud, Philip
    Germanos, Peter
    Dehle, Francis
    Norris, Sarah
    Tan, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis
    Sohn, H. S.
    Kwon, J. -W.
    Shin, S.
    Kim, H. -S.
    Kim, H.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (06) : 661 - 671
  • [6] Increasing progression-free survival in non-small cell lung cancer
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (09) : 498 - 498
  • [7] Progression-free survival and overall survival of pembrolizumab for patients with esophageal cancer: a meta-analysis
    Kurniawan, A.
    Wijovi, F.
    Angel, P.
    Priantono, D.
    Sari, C.
    Amelia, D. Astri Rivera
    Djatnika, D.
    Nasution, M. Arman
    Purlikasari, N. Prasasti
    Ariyanti, F.
    Wisman, B. Agustia
    Kurniawan, R.
    Sinurat, J.
    Ardian, A.
    Sugianto, G. Chandra Kirana
    Siregar, N. Novianti
    Dewi, N. Merlynda P.
    ANNALS OF ONCOLOGY, 2024, 35 : S1365 - S1365
  • [8] Progression-free survival and overall survival of pembrolizumab for patients with esophageal cancer: a meta-analysis
    Santoso, K. Aurelia
    Kosayuz, S.
    Atmaja, W. Surya
    Amalia, A. Irviani Ukhti
    Subroto, D. Ravinder Theodeus
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1365 - S1365
  • [9] Anlotinib as treatment for advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival and progression free survival
    Susanto, B.
    Marcella, E.
    Chen, S.
    Heriyanto, R. S.
    Tandiono, J.
    Wijovi, F.
    Tancherla, A.
    Kurniawan, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S792 - S792
  • [10] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Chirila, Costel
    Odom, Dawn
    Devercelli, Giovanna
    Khan, Shahnaz
    Sherif, Bintu N.
    Kaye, James A.
    Molnar, Istvan
    Sherrill, Beth
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (05) : 623 - 634
12345